• Retraction Note to: Analysis of loxoprofen in tablets, patches, and equine urine as tert-butyldimeth...

• Kim Young-Bae

• Seo Chan, Oh Su-In, Kwak Ju-Hwan, Jung Su-Min, Sin Eun-Su, Kim Hyun-Bin, Ji Moon-Gi, ...

• Archives of Pharmacal Research   2019  Volume.42  No.2 191 ~ 191

• Influence of CYP2D6 genetic polymorphism on pharmacokinetics of active moiety of tolterodine

• Byeon Ji-Yeong

• Lee Choong-Min, Lee Yea-Jin, Kim Young-Hoon, Kim Se-Hyung, Jung Eui-Hyun, Chae Won-Ki, Lee...

• Archives of Pharmacal Research   2019  Volume.42  No.2 182 ~ 190

• Development of BTK inhibitors for the treatment of B-cell malignancies

• Kim Hyung-Ook

• Archives of Pharmacal Research   2019  Volume.42  No.2 171 ~ 181

• Targeting epigenetics for cancer therapy

• Park Jong-Won

• Han Jeung-Whan

• Archives of Pharmacal Research   2019  Volume.42  No.2 159 ~ 170

• Peptide-based targeted therapeutics and apoptosis imaging probes for cancer therapy

• Vadevoo Sri Murugan Poongkavithai

• Gurung Smriti, Khan Fatima, Haque Md. Enamul, Gunassekaran Gowri Rangaswamy, Chi Lianhua, Permp...

• Archives of Pharmacal Research   2019  Volume.42  No.2 150 ~ 158

• Targeting cancer energy metabolism: a potential systemic cure for cancer

• Kim Soo-Youl

• Archives of Pharmacal Research   2019  Volume.42  No.2 140 ~ 149

• Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 as a molecular target in breast cancer: a the...

• Kim Ga-Ram

• Bhattarai Poshan Yugal, Choi Hong-Seok

• Archives of Pharmacal Research   2019  Volume.42  No.2 128 ~ 139

• Mitochondria-centric bioenergetic characteristics in cancer stem-like cells

• Shin Min-Kyue

• Cheong Jae-Ho

• Archives of Pharmacal Research   2019  Volume.42  No.2 113 ~ 127

• Rab25 and RCP in cancer progression

• Cho Kyung-Hwa

• Lee Hoi-Young

• Archives of Pharmacal Research   2019  Volume.42  No.2 101 ~ 112